Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Celgene

Status: Completed

Conditions: Chronic Lymphocytic Leukemia

Study type: Observational

Funder types: Industry

Identifiers

NCT01081015

Connect™ CLL

Details and patient eligibility

About

The purpose of the Connect™ Chronic Lymphocytic Leukemia (CLL) Disease Registry is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.

Enrollment: 1,494 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis with CLL
• Clinical decision made to initiate first-line therapy, second-line therapy or subsequent line of therapy prior to enrollment into the ConnectTM CLL registry, but within 2 months of enrollment
• Age≥18 years
• Willing and able to provide signed informed consent
• Willing and able to complete patient assessment questionnaires either alone or with minimal assistance from caregivers and/or trained site personnel

Exclusion criteria

• Participation in a clinical study in which study treatment is blinded
• Patient condition is considered terminal (i.e.<6 months to live)